Turning scientific discoveries into better treatments
The Frazer Institute is a modern research facility where clinical and basic science converge in the translational research of cancer, immunology and genomic medicine.
The Institute is host to over 300 researchers, students and support staff. It lays claim to global, world-changing discoveries such as the world’s first cervical cancer vaccine.
Based at the Translational Research Institute beside the Princess Alexandra Hospital, the Frazer Institute has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. Our position within the TRI allows for a much greater collaborative research environment, allowing our researchers to focus their efforts on turning their scientific discoveries into better treatments for diseases including a variety of cancers, osteoporosis, arthritis and other autoimmune diseases.
History
In 2007, the Frazer Institute was established as the sixth research institute of The University of Queensland. The Institute was formed through the amalgamation of UQ's Centre for Immunology and Cancer Research (CICR) and the Centre for Diabetes and Endocrinology Research (CDER).
The Translational Research Institute
The Frazer Institute has been part of the Translational Research Institute since late 2012. TRI is an Australian-first and will see Australia play a leading role in international efforts to address infectious disease, cancer and diabetes.